Literature DB >> 6940622

Different distribution of adriamycin in normal and leukaemic rats.

P Sonneveld, D W Van Bekkum.   

Abstract

Adriamycin (ADR) accumulates in well-perfused organs in the rat. This effect is especially evident for long periods in marrow and spleen of healthy animals. In rats bearing the Brown Norway Acute Myeloid Leukaemia (BNML) the in vivo distribution is significantly different. Maximum ADR levels in those organs which are morphologically infiltrated by leukaemic cells are significantly lower than in normal rats, while the persistence of measurable ADR concentrations does not change. On the contrary, ADR concentrations in organs not infiltrated by leukaemic cells are the same or slightly higher than in normal rats. Possible causes for these differences are either the differential properties of normal and leukaemic cells in their uptake and excretion of ADR, or anatomical and vascular changes. It is evident that, significantly different from normal. This observation may help in the prevention of toxicity by drug monitoring in serum.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6940622      PMCID: PMC2010630          DOI: 10.1038/bjc.1981.68

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Adriamycin-a review.

Authors:  S K Carter
Journal:  J Natl Cancer Inst       Date:  1975-12       Impact factor: 13.506

2.  Heart levels of adriamycin in normal and tumor-bearing mice.

Authors:  M G Donelli; A Martini; T Colombo; A Bossi; S Garattini
Journal:  Eur J Cancer       Date:  1976-11       Impact factor: 9.162

3.  Pharmacokinetics and metabolism of adriamycin in man.

Authors:  R S Benjamin; C E Riggs; N R Bachur
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

4.  A fluorometric assay for daunomycin and adriamycin in animal tissues.

Authors:  H S Schwartz
Journal:  Biochem Med       Date:  1973-06

5.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

Authors:  E J Freireich; E A Gehan; D P Rall; L H Schmidt; H E Skipper
Journal:  Cancer Chemother Rep       Date:  1966-05

6.  Relevance of recruitment-synchronization in the scheduling of 1-beta-D-arabinofuranosylcytosine in a slow-growing acute myeloid leukemia of the rat.

Authors:  M Aglietta; L Colly
Journal:  Cancer Res       Date:  1979-07       Impact factor: 12.701

7.  The relevance of cell kinetics for optimal scheduling of 1-beta-D-arabinofuranosyl cytosine and methotrexate in a slow growing acute myeloid leukemia (BNML).

Authors:  M Aglietta; P Sonneveld
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

8.  Comparative metabolism and excretion of adriamycin in man, monkey, and rat.

Authors:  P M Wilkinson; M Israel; W J Pegg; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

9.  Cytotoxicity of adriamycin and daunorubicin for normal and leukemia progenitor cells of man.

Authors:  R N Buick; H A Messner; J E Till; E A McCulloch
Journal:  J Natl Cancer Inst       Date:  1979-02       Impact factor: 13.506

10.  Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model.

Authors:  K K Chan; J L Cohen; J F Gross; K J Himmelstein; J R Bateman; Y Tsu-Lee; A S Marlis
Journal:  Cancer Treat Rep       Date:  1978-08
View more
  5 in total

Review 1.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

2.  Disposition of 14C-labelled 4'-epidoxorubicin and doxorubicin in the rat. A comparative study.

Authors:  F Arcamone; M Lazzati; G P Vicario; G Zini
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  Effects of advanced leukemia on hepatic drug-metabolizing activity in the mouse.

Authors:  G Powis; R N Harris; P J Basseches; K S Santone
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Deficits in the IgG+ memory B-cell recovery after anthracycline treatment is confined to the spleen of rhesus macaques.

Authors:  Gintare Lasaviciute; Andréas L Bricaud; Fredrika Hellgren; Hanna M Ingelman-Sundberg; Staffan Eksborg; Margreet Jonker; Krista G Haanstra; Ida Hed Myrberg; Eva Sverremark-Ekström; Karin Loré; Shanie Saghafian-Hedengren; Anna Nilsson
Journal:  Clin Transl Immunology       Date:  2020-07-02

Review 5.  A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology.

Authors:  Hala Skayneh; Batoul Jishi; Rita Hleihel; Maguy Hamieh; Nadine Darwiche; Ali Bazarbachi; Marwan El Sabban; Hiba El Hajj
Journal:  Genes (Basel)       Date:  2019-08-13       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.